טוען...
A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus
We are currently faced with a global infectious disease crisis which has been anticipated for decades. While many promising biotherapeutics are being tested, the search for a small molecule has yet to deliver an approved drug or therapeutic for the Ebola or similar filoviruses that cause haemorrhagi...
שמור ב:
| הוצא לאור ב: | F1000Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
F1000Research
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304229/ https://ncbi.nlm.nih.gov/pubmed/25653841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.5741.2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|